Randomized, controlled, parallel-group comparison of ambulatory and clinic blood pressure responses to amlodipine or enalapril during and after treatment in adult chinese patients with hypertension

Clinical Therapeutics

Volumn 26, Issue 8, 2004, Pages 1292-1304

  Tomlinson, Brian ^a,b   Woo, Jean ^a   Thomas, G Neil ^a   Chau, Yee Man ^a   Critchley, Julian A J H ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; ANTIHYPERTENSIVE AGENT; ENALAPRIL;

ADULT; AGED; ANKLE EDEMA; ANTIHYPERTENSIVE ACTIVITY; ARTHRALGIA; ARTHRITIS; ARTICLE; BLOOD PRESSURE MONITORING; CHINESE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; FLU LIKE SYNDROME; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MYALGIA; PARESTHESIA; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC HYPERTENSION; TREATMENT OUTCOME; TREATMENT WITHDRAWAL; ASIAN; BLOOD PRESSURE; COMPARATIVE STUDY; GENETICS; MIDDLE AGED; PATHOLOGY;

ADULT; AGED; AMLODIPINE; ANTIHYPERTENSIVE AGENTS; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; DOUBLE-BLIND METHOD; ENALAPRIL; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 6344222938     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/S0149-2918(04)80145-0     Document Type: Article

References (37)

1. World Health Organization (WHO), Guidelines Subcommittee 1999 WHO - International Society for Hypertension Guidelines for the Management of Hypertension J Hypertens 17 1999 151 183
2. [published correction appears in JAMA. 2003; 290: 197] Chobanian AV, Bakris GL, and Black HR for the National Heart, Lung and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee The Seventh Report of the Joint National Committee on Prevention, Detection Evaluation, and Treatment of High Blood Pressure: The JNC 7 report JAMA 289 2003 2560 2572
3. Hansson L, Zanchetti A, Carruthers SG for the HOT Study Group Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: Principle results of the Hypertension Optimal Treatment (HOT) randomised trial Lancet 351 1998 1755 1762
4. Jones DW Hypertension in East Asia Am J Hypertens 8 1995 111S 1145
5. (Suppl) Jamerson K, and Dequattro V The impact of ethnicity on response to antihypertensive therapy Am J Med 101 1996 S22 532
6. Woo KS, Norris RM, and Nicholls G Racial difference in incidence of cough with angiotensin-converting enzyme inhibitors (a tale of two cities) Am J Cardiol 75 1995 967 968
7. Elliott HL, Elawad M, Wilkinson R, and Singh SP Persistence of antihypertensive efficacy after missed doses: Comparison of amlodipine and nifedipine gastrointestinal therapeutic system J Hypertens 20 2002 333 338
8. Abernethy DR, Gutkowska J, and Winterbottom LM Effects of amlodipine, a long-acting dihydropyridine calcium antagonist in aging hypertension: Pharmacodynamics in relation to disposition Clin Pharmacol Ther 48 1990 76 86
9. Nayler WG, and Gu XH The unique binding properties of amlodipine: A long-acting calcium antagonist J Hum Hypertens 5 Suppl 1 1991 55 59
10. Osterloh I The safety of amlodipine Am Heart J 118 1989 1114 1119
11. Faulkner JK, McGibney D, and Chasseaud LF The pharmacokinetics of amlodipine in healthy volunteers after single intravenous and oral doses and after 14 repeated oral doses given once daily Br J Clin Pharmacol 22 1986 21 25
12. [published correction appears in Drugs. 1991; 41: 856] Murdoch D, and Heel RC Amlodipine A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in cardiovascular disease Drugs 41 1991 478 505
13. Donnelly R, Meredith PA, Elliott HL, and Reid JL Kinetic-dynamic relations and individual responses to enalapril Hypertension 15 1990 301 309
14. [published correction appears in N Engl J Med. 1992; 327: 1768] The Studies of Left Ventricular Dysfunction Investigators Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions N Engl J Med 327 1992 685 691
15. Girvin B, McDermott BJ, and Johnston GD A comparison of enalapril 20 mg once daily versus 10 mg twice daily in terms of blood pressure lowering and patient compliance J Hypertens 17 1999 1627 1631
16. Leenen FH, Myers MG, Joyner CD, and Toal CB Differential effects of once-daily antihypertensive drugs on blood pressure left ventricular mass and sympathetic activity: Nifedipine-GITS versus felodipineER versus enalapril Can J Cardiol 18 2002 1285 1293
17. Meredith PA, Donnelly R, and Elliott HL Prediction of the antihypertensive response to enalapril J Hypertens 8 1990 1085 1090
18. Hernandez-Hernandez R, Armas de Hernandez MJ, and Armas-Padilla MC The effects of missing a dose of enalapril versus amlodipine on ambulatory blood pressure Blood Press Monit 1 1996 121 126
19. Inman WH, Rawson NS, and Wilton LV Post-marketing surveillance of enalapril. I: Results of prescription-event monitoring BMJ 297 1988 826 829
20. Goldszer RC, Lilly LS, and Solomon HS Prevalence of cough during angiotensin-converting enzyme inhibitor therapy Am J Med 85 1988 887
21. Woo J, and Chan TY A high incidence of cough associated with combination therapy of hypertension with isradipine and lisinopril in Chinese subjects Br J Clin Pract 45 1991 178 180
22. Chan WK, Chan TY, and Luk WK A high incidence of cough in Chinese subjects treated with angiotensin converting enzyme inhibitors Eur J Clin Pharmacol 44 1993 299 300
23. Woo KS, and Nicholls MG High prevalence of persistent cough with angiotensin converting enzyme inhibitors in Chinese BrJ Clin Pharmacol 40 1995 141 144
24. Omvik P, Thaulow E, and Herland OB Double-blind, parallel, comparative study on quality of life during treatment with amlodipine or enalapril in mild or moderate hypertensive patients: A multicentre study J Hypertens 11 1993 103 113
25. Clark LT Improving compliance and increasing control of hypertension: Needs of special hypertensive populations Am Heart J 121 1991 664 669
26. Rudd P Partial compliance: Implications for clinical practice J Cardiovasc Pharmacol 22 Suppl A 1993 S1 S5
27. Eisen SA, Miller DK, and Woodward RS The effect of prescribed daily dose frequency on patient medication compliance Arch Intern Med 150 1990 1881 1884
28. [published correction appears in Eur J Clin Pharmacol. 1995; 48: 314] Detry JM, Block P, De Backer G, Degaute JP for the Belgian Collaborative Study Group Patient compliance and therapeutic coverage: Comparison of amlodipine and slow release nifedipine in the treatment of hypertension Eur J Clin Pharmacol 47 1995 477 481
29. Waeber B, Erne P, Saxenhofer H, and Heynen G Use of drugs with more than a twenty-four-hour duration of action J Hypertens Suppl 12 1994 S67 S71
30. Omboni S, Parati G, Zanchetti A, and Mancia G Calculation of trough: peak ratio of antihypertensive treatment from ambulatory blood pressure: Methodological aspects J Hypertens 13 1995 1105 1112
31. Materson BJ, Reda DJ, Cushman WC for the Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents Department of Veterans Affairs single-drug therapy of hypertension study Revised figures and new data Am J Hypertens 8 1995 189 192
32. Chan JC, Cockram CS, and Nicholls MG Comparison of enalapril and nifedipine in treating non-insulin dependent diabetes associated with hypertension: One year analysis BMJ 305 1992 981 985
33. Smith DH Treatment of hypertension with an angiotensin II-receptor antagonist compared with an angiotensin-converting enzyme inhibitor: A review of clinical studies of telmisartan and enalapril Clin Ther 24 2002 1484 1501
34. Fagard R, Lijnen P, and Pardaens K A randomised, placebo-controlled, double-blind, crossover study of losartan and enalapril in patients with essential hypertension J Hum Hypertens 15 2001 161 167
35. Zanchetti A, Omboni S for the Italian Candesartan Study Group Comparison of candesartan versus enalapril in essential hypertension Am J Hypertens 14 2001 129 134
36. Coca A, Calvo C, Garcia-Puig J for the Monitorizacion Ambulatoria Presion Arterial APROVEL (MAPAVEL) Investigators A multicenter, randomized, double-blind comparison of the efficacy and safety of irbesartan and enalapril in adults with mild to moderate essential hypertension, as assessed by ambulatory blood pressure monitoring: The MAPAVEL Study Clin Ther 24 2002 126 138
37. Letter Tomlinson B, Young RP, and Chan JC Pharmacoepidemiology of ACE inhibitor-induced cough Drug Saf 16 1997 150 151